Yu, Zhengtian
Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Qi, W., Zhao, K., Gu, J., Huang, Y., Wang, Y., Zhang, H., Zhang, M., Zhang, J., Yu, Z., Li, L., et al. (2017) · Nature Chemical Biology
Epigenetics and DNA MethylationCancer-related gene regulation
Cited by 316
- Verified
Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors
Gibaja, V, Shen, F., Harari, J., Korn, J., Ruddy, D., Saenz-Vash, V, Zhai, H., Rejtar, T., Paris, C. G., Yu, Z., et al. (2016) · Oncogene
Epigenetics and DNA MethylationChromatin Remodeling and Cancer
Cited by 149
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free